Research map: Caring for Older Adults with Acute Myeloid Leukemia: Best Practices for Aligning Patient Fitness and Preference with Available Therapies

Back to the article

Papers in this map

  1. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia · Courtney Denton Dinardo · 2020 · 2931 citations · Cited by this paper
  2. Loneliness and Initiation of Potentially Inappropriate Pain and Psychotropic Medications: A Retrospective Cohort Study · 2026 · Related
  3. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia · Eytan M. Stein · 2017 · 1516 citations · Cited by this paper
  4. Association Between Anticholinergic Burden and Dry Mouth Severity in Acutely Ill Older Adults · 2026 · Related
  5. Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML · Courtney Denton Dinardo · 2018 · 1465 citations · Cited by this paper
  6. Effectiveness of Patient-Directed Education to Sustain Deprescribing: A Pragmatic Trial · 2025 · Related
  7. CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia · Jeffrey E. Lancet · 2018 · 1024 citations · Cited by this paper
  8. The Association Between Anticholinergic Burden and Treatment-Related Complications in Older Adults with Cancer · 2026 · Related
  9. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study · Supriya Gupta Mohile · 2021 · 602 citations · Cited by this paper
  10. Adapting the Geriatric Medicine 5Ms Framework to Geriatric Dermatology · 2026 · Related
  11. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update · William Dale · 2023 · 500 citations · Cited by this paper
  12. Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML · 2025 · Related
  13. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia · Heidi D. Klepin · 2013 · 429 citations · Cited by this paper
  14. Diabetic Peripheral Neuropathy: New Diagnostics and Treatment Perspectives · 2025 · Related
  15. Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial · Harry Paul Erba · 2023 · 418 citations · Cited by this paper
  16. Potentially Inappropriate Prescription and Its Association with Index Hospitalization: A Multicenter, Cross-Sectional Study Using TIME Criteria · 2026 · Related
  17. Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer · Enrique Soto‐Pérez‐de‐Celis · 2018 · 409 citations · Cited by this paper
  18. Cross-Sectional Study on Factors Associated with Hyperpolypharmacy and Medication Adherence in Older Adults with Multimorbidity and Polypharmacy · 2025 · Related
  19. Quality of life versus length of life considerations in cancer patients: A systematic literature review · Anne Shrestha · 2019 · 390 citations · Cited by this paper
  20. Effect of a Multifaceted Pharmacist-Led Intervention on Medication Appropriateness and Medication Burden in Patients Admitted to an Acute Geriatric Ward: Results from the ASPIRE Trial · 2026 · Related
  21. Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial · Sergio Amadori · 2016 · 362 citations · Cited by this paper
  22. Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401 · Arti Hurria · 2011 · 352 citations · Cited by this paper
  23. Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD · Richard F. Schlenk · 2018 · 291 citations · Cited by this paper
  24. De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017 · Koji Sasaki · 2021 · 287 citations · Cited by this paper
  25. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations · Hartmut Döhner · 2024 · 242 citations · Cited by this paper
  26. Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101) · Ghayas C. Issa · 2024 · 232 citations · Cited by this paper
  27. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial · Jeffrey E. Lancet · 2021 · 229 citations · Cited by this paper
  28. Long‐term follow‐up of VIALE‐A : Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia · Keith William Pratz · 2024 · 226 citations · Cited by this paper
  29. Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review · Clark DuMontier · 2020 · 190 citations · Cited by this paper
  30. Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia · Areej R El-Jawahri · 2020 · 187 citations · Cited by this paper
  31. Screening Tools for Identifying Older Adults With Cancer Who May Benefit From a Geriatric Assessment · Maja Garcia · 2021 · 156 citations · Cited by this paper
  32. The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy · Marije Emilie Hamaker · 2014 · 148 citations · Cited by this paper
  33. Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3 mut+ AML ineligible for intensive chemotherapy · Eunice S. Wang · 2022 · 137 citations · Cited by this paper
  34. Geriatric assessment in older patients with a hematologic malignancy: a systematic review · Ellen R. M. Scheepers · 2020 · 113 citations · Cited by this paper
  35. Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient—A Systematic Review · Nelleke Seghers · 2022 · 113 citations · Cited by this paper
  36. Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer · Claudia Martinez‐Tapia · 2017 · 105 citations · Cited by this paper
  37. Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia · Thomas William LeBlanc · 2018 · 101 citations · Cited by this paper
  38. Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy · Sangeetha Venugopal · 2022 · 99 citations · Cited by this paper
  39. Health outcomes and implementation barriers and facilitators of comprehensive geriatric assessment in community settings: a systematic integrative review [PROSPERO registration no.: CRD42021229953] · Grace Sum · 2022 · 93 citations · Cited by this paper

Source: OpenAlex (CC0)